Analystreport

Coherus BioSciences, Inc. (NASDAQ: CHRS) had its price target lowered by analysts at Truist Financial Co. from $24.00 to $22.00.

Coherus BioSciences, Inc.  (CHRS) 
Last coherus biosciences, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.coherus.com